PBAC Report now available - Options for listing PD-(L)1 checkpoint inhibitors for multiple cancer indications on the PBS
Page last updated: 22 March 2019
The Pharmaceutical Benefits Advisory Committee’s (PBAC) Report to the Hon. Greg Hunt MP, Minister for Health on “Options for listing PD(L)-1 checkpoint inhibitors for multiple cancer indications on the PBS” is now available on the PBS website.
